Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI,
2022,
Antonio J. Vallejo-Vaz ,
Sarah Bray ,
Guillermo Villa ,
Julia Brandts ,
Gaia Kiru ,
Jennifer Murphy ,
Maciej Banach ,
Stefano De Servi ,
Dan Gaita ,
Ioanna Gouni-Berthold ,
[et. al] ,
Cardiovascular Drugs and Therapy, 1--13, ISSN: 0920-3206, eISSN: 1573-7241,
bibliogr.
rys.
tab.
wykr.
summ.
Słowa kluczowe: Atherosclerotic cardiovascular disease, Cardiovascular disease prevention, Cardiovascular risk, LDL-C, Lipid-lowering, Statins
Kod: CZR-N-WYKAZ
BibTeX
(pkt. 100)
DOI: 10.1007/s10557-022-07343-x
